These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25072382)
1. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Launois R; Le Moine JG; Uzzan B; Fiestas Navarrete LI; Benamouzig R Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):978-89. PubMed ID: 25072382 [TBL] [Abstract][Full Text] [Related]
2. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests. Meklin J; SyrjÄnen K; Eskelinen M Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599 [TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany. Brenner H; Hoffmeister M; Birkner B; Stock C Am J Gastroenterol; 2014 Mar; 109(3):427-35. PubMed ID: 24343548 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis. Li R; Liu J; Xue H; Huang G Int J Cancer; 2012 Oct; 131(8):1837-45. PubMed ID: 22261915 [TBL] [Abstract][Full Text] [Related]
6. Screening for colon cancer: A test for occult blood. Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558 [TBL] [Abstract][Full Text] [Related]
8. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients. Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467 [TBL] [Abstract][Full Text] [Related]
9. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening. Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670 [TBL] [Abstract][Full Text] [Related]
10. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629 [TBL] [Abstract][Full Text] [Related]
11. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Tinmouth J; Lansdorp-Vogelaar I; Allison JE Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988 [TBL] [Abstract][Full Text] [Related]
13. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results. Brenner H; Hoffmeister M; Birkner B; Stock C Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771 [TBL] [Abstract][Full Text] [Related]
14. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Brenner H; Tao S Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981 [TBL] [Abstract][Full Text] [Related]
15. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. Zhu MM; Xu XT; Nie F; Tong JL; Xiao SD; Ran ZH J Dig Dis; 2010 Jun; 11(3):148-60. PubMed ID: 20579218 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Hundt S; Haug U; Brenner H Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905 [TBL] [Abstract][Full Text] [Related]
17. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening. Tao S; Brenner H Eur J Cancer Prev; 2013 Jul; 22(4):305-10. PubMed ID: 23702679 [TBL] [Abstract][Full Text] [Related]
18. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426 [TBL] [Abstract][Full Text] [Related]
19. Fecal occult blood test in colorectal cancer screening. Li JN; Yuan SY J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325 [TBL] [Abstract][Full Text] [Related]